naproxen sodium pm
Generic: diphenhydramine hydrochloride, naproxen sodium
Labeler: kroger companyDrug Facts
Product Profile
Brand Name
naproxen sodium pm
Generic Name
diphenhydramine hydrochloride, naproxen sodium
Labeler
kroger company
Dosage Form
TABLET
Routes
Active Ingredients
diphenhydramine hydrochloride 25 mg/1, naproxen sodium 220 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
30142-753
Product ID
30142-753_c100a604-8175-43a6-a600-ddb561bd2c75
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA208499
Listing Expiration
2026-12-31
Marketing Start
2019-06-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
30142753
Hyphenated Format
30142-753
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen sodium pm (source: ndc)
Generic Name
diphenhydramine hydrochloride, naproxen sodium (source: ndc)
Application Number
ANDA208499 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 220 mg/1
Packaging
- 80 TABLET in 1 BOTTLE (30142-753-27)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c100a604-8175-43a6-a600-ddb561bd2c75", "openfda": {"unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["d5dafdd0-968d-4ee6-9461-1f72d3255240"], "manufacturer_name": ["Kroger Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "80 TABLET in 1 BOTTLE (30142-753-27)", "package_ndc": "30142-753-27", "marketing_start_date": "20190620"}], "brand_name": "naproxen sodium pm", "product_id": "30142-753_c100a604-8175-43a6-a600-ddb561bd2c75", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "30142-753", "generic_name": "diphenhydramine hydrochloride, naproxen sodium", "labeler_name": "Kroger Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "naproxen sodium pm", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208499", "marketing_category": "ANDA", "marketing_start_date": "20190620", "listing_expiration_date": "20261231"}